Results 161 to 170 of about 5,080,573 (227)

Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment. [PDF]

Cancer Rep (Hoboken)
Lazure P, Eyre TA, Niemann CU, Shah NN, Dreyling M, Cymbalista F, Peloquin S, Znamensky S, Goebel B, Murray S.   +9 more
europepmc   +1 more source

Mantle Cell Lymphoma Mimicking Parotid Neoplasm: A Rare Case Report. [PDF]

Iran J Otorhinolaryngol
Gupta T, Yadav S, Naseem AA, Singh SK, Rashmi R.   +4 more
europepmc   +1 more source

TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma. [PDF]

Ann Hematol
Liu S, Zhou S, Zhang W, Wang J, Wang L, Li C, Chen Y, Qi W, Yang P, Jing H.   +9 more
europepmc   +1 more source

Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse. [PDF]

Am J Hematol
Ananth S, Agarwal N, Sahaf B, Jacob A, Lee LW, Simmons H, Kirsch I, Bharadwaj S, Weng WK, Smith M, Dahiya S, Miklos D, Frank MJ.   +12 more
europepmc   +1 more source

Beyond the CAR-T horizon in mantle cell lymphoma. [PDF]

Blood Adv
Lew TE, Seymour JF.
europepmc   +1 more source

LncRNA IRAIN inhibits mantle cell lymphoma progression by inducing cell cycle arrest and apoptosis: an in vitro study. [PDF]

Sci Rep
Lin P, Zhang Y, Lu L, Ma X, Huang Y.
europepmc   +1 more source

Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma in asia: redefining the role of allogeneic haematopoietic stem cell transplantation. [PDF]

Ann Hematol
Ng LCK, Tan JY, Ong SY, Nagarajan C, Poon MLM, Ho AYL, Lim FWI, Chen Y.   +7 more
europepmc   +1 more source

Clinical Impact of a Germline CD19 Variant on Treatment Outcome After CAR-T Cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma. [PDF]

Cancers (Basel)
Ruckstuhl SA, Seipel K, Shaforostova I, Bertschinger M, Bacher U, Pabst T.   +5 more
europepmc   +1 more source

Multifaceted cfDNA profiling in mantle cell lymphoma. [PDF]

Blood Adv
Sworder BJ, Herrera AF.
europepmc   +1 more source

Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma. [PDF]

Exp Hematol Oncol
Yan F, Jiang V, Jordan A, Che Y, Liu Y, Cai Q, Xue Y, Li Y, McIntosh J, Chen Z, Vargas J, Nie L, Yao Y, Lee HH, Wang W, Bigcal JR, Badillo M, Meena J, Flowers C, Zhou J, Zhao Z, Simon LM, Wang M.   +22 more
europepmc   +1 more source